Biomerica (BMRA) Return on Sales (2010 - 2026)

Biomerica's Return on Sales history runs 17 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.01%; the TTM figure through Feb 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
• Return on Sales came in at 0.01% for Q1 2026 at Biomerica, down from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2025 to a low of 0.02% in Q2 2025.
• A 5-year average of 0.01% and a median of 0.01% in 2025 frame the typical range for Return on Sales.
• On a YoY basis, Return on Sales climbed as much as 1 bps in 2022 and fell as far as 1 bps in 2022.
• Biomerica's Return on Sales stood at 0.01% in 2022, then advanced by 12 bps to 0.01% in 2023, then soared by 40 bps to 0.01% in 2024, then sank by 88 bps to 0.01% in 2025, then retreated by 22 bps to 0.01% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 0.01%, 0.01%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison